Literature DB >> 8359270

Calmodulin mediates melatonin cytoskeletal effects.

G Benítez-King1, F Antón-Tay.   

Abstract

In this article, we review the data concerning melatonin interactions with calmodulin. The kinetics of melatonin-calmodulin binding suggest that the hormone modulates cell activity through intracellular binding to the protein at physiological concentration ranges. Melatonin interaction with calmodulin may allow the hormone to modulate rhythmically many cellular functions. Melatonin's effect on tubulin polymerization, and cytoskeletal changes in MDCK and N1E-115 cells cultured with melatonin, suggest that at low concentrations (10(-9) M) cytoskeletal effects are mediated by its antagonism to Ca2+-calmodulin. At higher concentrations (10(-5)M) non-specific binding of melatonin to tubulin occurs thus overcoming the specific melatonin antagonism to Ca2+-calmodulin. Since the structures of melatonin and calmodulin are phylogenetically well preserved, calmodulin-melatonin interaction probably represents a major mechanism for regulation and synchronization of cell physiology.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8359270     DOI: 10.1007/bf01923944

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  69 in total

Review 1.  Effects of melatonin on vertebrate circadian systems.

Authors:  V M Cassone
Journal:  Trends Neurosci       Date:  1990-11       Impact factor: 13.837

2.  Changes in the organization of the neuritic cytoskeleton during nerve growth factor-activated differentiation of PC12 cells: a serial electron microscopic study of the development and control of neurite shape.

Authors:  J R Jacobs; J K Stevens
Journal:  J Cell Biol       Date:  1986-09       Impact factor: 10.539

3.  Characterization of [3H]Ro 5-4864 binding to calmodulin using a rapid filtration technique.

Authors:  P F Morgan; J Patel; P J Marangos
Journal:  Biochem Pharmacol       Date:  1987-12-15       Impact factor: 5.858

4.  The control of granule movement in fish melanophores.

Authors:  N Grundström; J O Karlsson; R G Andersson
Journal:  Acta Physiol Scand       Date:  1985-11

5.  Role of cyclic AMP in mediating the effects of MSH, norepinephrine, and melatonin on frog skin color.

Authors:  K Abe; G A Robison; G W Liddle; R W Butcher; W E Nicholson; C E Baird
Journal:  Endocrinology       Date:  1969-10       Impact factor: 4.736

6.  Regulation of cAMP concentration by calmodulin-dependent cyclic nucleotide phosphodiesterase.

Authors:  R K Sharma; J H Wang
Journal:  Biochem Cell Biol       Date:  1986-11       Impact factor: 3.626

7.  Occluding junctions and cytoskeletal components in a cultured transporting epithelium.

Authors:  I Meza; G Ibarra; M Sabanero; A Martínez-Palomo; M Cereijido
Journal:  J Cell Biol       Date:  1980-12       Impact factor: 10.539

8.  Melatonin in seasonal affective disorder and phototherapy.

Authors:  N E Rosenthal; D A Sack; F M Jacobsen; S P James; B L Parry; J Arendt; L Tamarkin; T A Wehr
Journal:  J Neural Transm Suppl       Date:  1986

9.  Melatonin modifies calmodulin cell levels in MDCK and N1E-115 cell lines and inhibits phosphodiesterase activity in vitro.

Authors:  G Benítez-King; L Huerto-Delgadillo; F Antón-Tay
Journal:  Brain Res       Date:  1991-08-23       Impact factor: 3.252

10.  Regulation of mitosis. II. Interaction of isopropyl N-phenylcarbamate and melatonin.

Authors:  W T Jackson
Journal:  J Cell Sci       Date:  1969-11       Impact factor: 5.285

View more
  29 in total

1.  Microarray technology in studying the effect of melatonin on gene expression in the mouse heart.

Authors:  S V Anisimov; K R Boheler; V N Anisimov; K P Boheler
Journal:  Dokl Biol Sci       Date:  2002 Mar-Apr

2.  Therapeutic potential of melatonin and its analogs in Parkinson's disease: focus on sleep and neuroprotection.

Authors:  Venkatramanujam Srinivasan; Daniel P Cardinali; Uddanapalli S Srinivasan; Charanjit Kaur; Gregory M Brown; D Warren Spence; Rüdiger Hardeland; Seithikurippu R Pandi-Perumal
Journal:  Ther Adv Neurol Disord       Date:  2011-09       Impact factor: 6.570

Review 3.  Expression and putative functions of melatonin receptors in malignant cells and tissues.

Authors:  Cem Ekmekcioglu
Journal:  Wien Med Wochenschr       Date:  2014-07-15

4.  Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer amyloid peptide.

Authors:  M A Pappolla; M Sos; R A Omar; R J Bick; D L Hickson-Bick; R J Reiter; S Efthimiopoulos; N K Robakis
Journal:  J Neurosci       Date:  1997-03-01       Impact factor: 6.167

5.  In vitro stimulation of protein kinase C by melatonin.

Authors:  F Antón-Tay; G Ramírez; I Martínez; G Benítez-King
Journal:  Neurochem Res       Date:  1998-05       Impact factor: 3.996

Review 6.  The role of melatonin in Multiple Sclerosis.

Authors:  Charalampos Skarlis; Maria Anagnostouli
Journal:  Neurol Sci       Date:  2019-12-16       Impact factor: 3.307

7.  Melatonin: neuritogenesis and neuroprotective effects in crustacean x-organ cells.

Authors:  Gregory A Cary; Anne S Cuttler; Kirsten A Duda; Escar T Kusema; Jennifer A Myers; Andrea R Tilden
Journal:  Comp Biochem Physiol A Mol Integr Physiol       Date:  2011-12-16       Impact factor: 2.320

8.  Cardiovascular effects of melatonin in hypertensive patients well controlled by nifedipine: a 24-hour study.

Authors:  P Lusardi; E Piazza; R Fogari
Journal:  Br J Clin Pharmacol       Date:  2000-05       Impact factor: 4.335

Review 9.  Molecular mechanisms of melatonin's inhibitory actions on breast cancers.

Authors:  Sara Proietti; Alessandra Cucina; Russel J Reiter; Mariano Bizzarri
Journal:  Cell Mol Life Sci       Date:  2012-09-25       Impact factor: 9.261

10.  Dose-dependent dual effect of melatonin on ototoxicity induced by amikacin in adult rats.

Authors:  Tamer Erdem; Orhan Ozturan; Mustafa Iraz; Murat Cem Miman; Ercument Olmez
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-05-28       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.